Odyssey Therapeutics is led by its founder, Dr. Gary D. Glick, who serves as the President and Chief Executive Officer. Recognized as an experienced serial biotech entrepreneur, he has successfully founded and built multiple clinical-stage biopharmaceutical ventures prior to establishing Odyssey. Under his leadership, the company has rapidly raised hundreds of millions of dollars in venture financing and public capital to fuel its drug discovery engine targeting serious autoimmune diseases and oncology indications.